These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 32618526)

  • 1. Evaluation of human resources needed and comparison with human resources available to implement emergency vaccination in case of foot and mouth disease outbreaks in Tunisia.
    Marsot M; Durand B; Ben Hammouda W; Hadj Ammar H; Zrelli M; Khorchani R
    Epidemiol Infect; 2020 Jun; 148():e128. PubMed ID: 32618526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatio-temporal patterns of foot-and-mouth disease transmission in cattle between 2007 and 2015 and quantitative assessment of the economic impact of the disease in Niger.
    Souley Kouato B; Thys E; Renault V; Abatih E; Marichatou H; Issa S; Saegerman C
    Transbound Emerg Dis; 2018 Aug; 65(4):1049-1066. PubMed ID: 29508559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Review of OIE Country Status Recovery Using Vaccinate-to-Live Versus Vaccinate-to-Die Foot-and-Mouth Disease Response Policies II: Waiting Periods After Emergency Vaccination in FMD Free Countries.
    Geale DW; Barnett PV; Clarke GW; Davis J; Kasari TR
    Transbound Emerg Dis; 2015 Aug; 62(4):388-406. PubMed ID: 24131661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with within-herd transmission of serotype A foot-and-mouth disease virus in cattle, during the 2001 outbreak in Argentina: a protective effect of vaccination.
    Brito BP; Perez AM; Cosentino B; Rodriguez LL; König GA
    Transbound Emerg Dis; 2011 Oct; 58(5):387-93. PubMed ID: 21896154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The field effectiveness of routine and emergency vaccination with an inactivated vaccine against foot and mouth disease.
    Elnekave E; Li Y; Zamir L; Even-Tov B; Hamblin P; Gelman B; Hammond J; Klement E
    Vaccine; 2013 Jan; 31(6):879-85. PubMed ID: 23246551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modelling the field personnel resources to control foot-and-mouth disease outbreaks in New Zealand.
    Sanson RL; Rawdon TG; van Andel M; Yu Z
    Transbound Emerg Dis; 2022 Nov; 69(6):3926-3939. PubMed ID: 36397293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management strategies for vaccinated animals after an outbreak of foot-and-mouth disease and the impact on return to trade.
    Bradhurst R; Garner G; East I; Death C; Dodd A; Kompas T
    PLoS One; 2019; 14(10):e0223518. PubMed ID: 31603929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Review of OIE Country Status Recovery Using Vaccinate-to-Live Versus Vaccinate-to-Die Foot-and-Mouth Disease Response Policies I: Benefits of Higher Potency Vaccines and Associated NSP DIVA Test Systems in Post-Outbreak Surveillance.
    Barnett PV; Geale DW; Clarke G; Davis J; Kasari TR
    Transbound Emerg Dis; 2015 Aug; 62(4):367-87. PubMed ID: 24112127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The economic impacts of foot and mouth disease - what are they, how big are they and where do they occur?
    Knight-Jones TJ; Rushton J
    Prev Vet Med; 2013 Nov; 112(3-4):161-73. PubMed ID: 23958457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the benefits of vaccination when used in combination with stamping-out measures against hypothetical introductions of foot-and-mouth disease into New Zealand: a simulation study.
    Sanson RL; Rawdon T; Owen K; Hickey K; van Andel M; Yu ZD
    N Z Vet J; 2017 May; 65(3):124-133. PubMed ID: 27870922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing control strategies against foot-and-mouth disease: will vaccination be cost-effective in Denmark?
    Boklund A; Halasa T; Christiansen LE; Enøe C
    Prev Vet Med; 2013 Sep; 111(3-4):206-19. PubMed ID: 23791121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantifying the Value of Perfect Information in Emergency Vaccination Campaigns.
    Bradbury NV; Probert WJ; Shea K; Runge MC; Fonnesbeck CJ; Keeling MJ; Ferrari MJ; Tildesley MJ
    PLoS Comput Biol; 2017 Feb; 13(2):e1005318. PubMed ID: 28207777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategy for the control of foot-and-mouth disease in Uruguay.
    Ugarte R
    Dev Biol (Basel); 2004; 119():415-21. PubMed ID: 15742654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macroeconomic impact of foot-and-mouth disease vaccination strategies for an outbreak in the Midwestern United States: A computable general equilibrium.
    Miller M; Liu L; Shwiff S; Shwiff S
    Transbound Emerg Dis; 2019 Jan; 66(1):156-165. PubMed ID: 30113131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analyzing the Foot and Mouth Disease outbreak as from 2008 to 2014 in cattle and buffaloes in Sri Lanka.
    Gunasekera UC; Sivasothy A; Wedasingha N; Thayaparan S; Rotewewa B; Muralithas M; Baumann MPO; Punyapornwithaya V
    Prev Vet Med; 2017 Dec; 148():78-88. PubMed ID: 29157377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating vaccination strategies to control foot-and-mouth disease: a country comparison study.
    Rawdon TG; Garner MG; Sanson RL; Stevenson MA; Cook C; Birch C; Roche SE; Patyk KA; Forde-Folle KN; Dubé C; Smylie T; Yu ZD
    Epidemiol Infect; 2018 Jul; 146(9):1138-1150. PubMed ID: 29785893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The macro-economic impact of a foot-and-mouth disease incursion in New Zealand.
    Belton DJ
    Dev Biol (Basel); 2004; 119():457-61. PubMed ID: 15742660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Foot-and-Mouth disease control using vaccination: the Dutch experience in 2001.
    Pluimers FH
    Dev Biol (Basel); 2004; 119():41-9. PubMed ID: 15742617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: Use in emergency outbreak response.
    Golde WT; Pacheco JM; Duque H; Doel T; Penfold B; Ferman GS; Gregg DR; Rodriguez LL
    Vaccine; 2005 Dec; 23(50):5775-82. PubMed ID: 16153756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefit-cost analysis of vaccination and preemptive slaughter as a means of eradicating foot-and-mouth disease.
    Bates TW; Carpenter TE; Thurmond MC
    Am J Vet Res; 2003 Jul; 64(7):805-12. PubMed ID: 12856762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.